What Is Ventricular Enlargement of the Brain?

Ventricular enlargement of the brain, medically called ventriculomegaly, is a condition in which the fluid-filled cavities inside the brain (the ventricles) become abnormally large. It happens when cerebrospinal fluid either accumulates faster than it can be absorbed, or when surrounding brain tissue shrinks and the ventricles passively expand to fill the space. Ventriculomegaly is not a single disease but rather a radiological finding that can stem from dozens of different causes, ranging from congenital blockages in a developing fetus to age-related conditions in older adults. Understanding the distinction between those causes matters, because treatment and outlook vary dramatically depending on what is driving the enlargement.

The Ventricles and Why They Exist

Your brain contains four interconnected chambers: two large lateral ventricles (one in each hemisphere), a smaller third ventricle deeper in the midline, and a fourth ventricle near the brainstem. These chambers are lined with specialized cells and filled with cerebrospinal fluid (CSF), a clear liquid that cushions the brain, delivers nutrients, and carries away waste products. Under the traditional view, CSF is produced mainly by a tissue called the choroid plexus inside the ventricles, then flows outward through narrow passages into the spaces surrounding the brain and spinal cord, and is eventually reabsorbed into the bloodstream. More recent research suggests the picture is more complex: CSF and the fluid that bathes brain tissue are closely linked, and a significant amount of production and absorption happens not just in the ventricles but throughout the brain’s capillary network and even through lymphatic channels.

Normally the ventricles are modest in size, proportional to the brain around them. The system works because fluid production and absorption stay roughly in balance. When that balance is disrupted, or when the brain itself loses volume, the ventricles grow larger than they should be.

Two Fundamentally Different Reasons the Ventricles Enlarge

Clinicians draw a sharp line between two broad categories of ventriculomegaly, because the implications are very different.

The first category is hydrocephalus, where CSF accumulates under pressure (or sometimes at near-normal pressure) and actively pushes the ventricle walls outward. This can happen because something blocks CSF flow, because the body cannot absorb CSF fast enough, or because of abnormal CSF dynamics. The accumulating fluid compresses brain tissue and, if untreated, causes progressive neurological damage.

The second category is sometimes called hydrocephalus ex vacuo, which is not truly hydrocephalus at all. Here, the ventricles enlarge passively because the brain tissue around them has shrunk, as happens in neurodegenerative diseases or after significant brain injury. The fluid simply fills the space the brain used to occupy. CSF pressure is normal, and the enlargement is a marker of tissue loss rather than a fluid circulation problem.

Telling these two apart is critically important because treatment strategies differ completely. True hydrocephalus usually needs surgical intervention to restore fluid balance. Hydrocephalus ex vacuo is managed by treating the underlying cause of brain volume loss, if one exists, rather than by draining fluid.

Types of Hydrocephalus

Within the hydrocephalus category, two further distinctions shape how doctors approach treatment.

Obstructive (non-communicating) hydrocephalus occurs when a physical blockage prevents CSF from flowing through the narrow passages connecting the ventricles. The most common site of obstruction is the aqueduct of Sylvius, a slender channel between the third and fourth ventricles. A tumor, a cyst, or a congenital malformation can plug this passage. Certain genetic mutations, such as those in the CRB2 gene, can cause complete closure (atresia) of the aqueduct during fetal development, leading to severe congenital hydrocephalus.

⁴

Communicating hydrocephalus occurs when CSF can flow freely through the ventricles but is not absorbed properly once it reaches the outer brain surfaces. The traditional explanation points to malfunction of the arachnoid granulations, tiny structures that normally drain CSF into the venous sinuses. But research in animal models has also implicated lymphatic vessels in the ethmoid bone region, suggesting that impaired lymphatic absorption can contribute to this form of hydrocephalus as well.

⁵

A third condition, idiopathic normal pressure hydrocephalus (iNPH), blurs these lines. In iNPH, the ventricles are enlarged and CSF dynamics are abnormal, yet the measured CSF pressure often falls within a technically normal range. Research has found that increased pulsatile CSF movement and reduced drainage gradually stretch the ventricle walls. The resulting chronic pressure changes can reduce blood flow in surrounding brain tissue, trigger inflammation, and contribute to damage in both white and gray matter.

⁶

Causes Across Different Life Stages

Ventricular enlargement can appear at virtually any age, but the underlying causes cluster differently depending on when the condition develops.

Before Birth

Fetal ventriculomegaly is typically detected on routine prenatal ultrasound. It is a heterogeneous condition with widely varying causes and outcomes.

⁷

It can result from abnormal CSF circulation, disorders of how brain cells migrate during development, or destructive processes like infection or hemorrhage. In mild cases (ventricle width between 10 and 15 mm), other structural brain abnormalities are found in roughly 10 to 50 percent of fetuses. In severe cases (above 15 mm), associated malformations appear in 60 percent or more.

⁸

The risk of chromosomal and genetic disorders is high enough that invasive genetic testing is typically recommended when fetal ventriculomegaly is identified.

⁹

After Traumatic Brain Injury

Ventricular enlargement is a surprisingly common consequence of moderate to severe head injuries. In one study, ventriculomegaly was found in about 39 percent of patients with severe head injury and 27 percent of those with moderate head injury. The enlargement developed quickly: it was already visible on imaging four weeks after injury in over half of the affected patients and within two months in about 70 percent.

¹⁰

Post-traumatic ventriculomegaly carries real long-term risks, including increased susceptibility to memory disorders and epilepsy.

¹¹

In Older Adults

Idiopathic normal pressure hydrocephalus predominantly affects people over 60. Research has identified several risk factors that may contribute, including chronic alcohol consumption, sleep apnea, diabetes, and hypertension. Alcohol may damage the motile cilia that line the ventricle walls and help move CSF. Uncontrolled diabetes increases the sugar concentration in CSF, raising its viscosity and changing how it flows. Sleep apnea, diabetes, and hypertension are all linked to impaired exchange between CSF and the fluid in brain tissue.

¹²

What Symptoms Look Like

Symptoms depend heavily on the cause, the speed of onset, and the patient’s age. In infants, the skull bones have not yet fused, so increased CSF pressure can cause the head to enlarge visibly. In older children and adults, the skull is rigid, and mounting pressure produces headaches, nausea, vision changes, and sometimes altered consciousness.

The classic triad of symptoms in normal pressure hydrocephalus includes difficulty walking (a wide-based, shuffling gait), urinary incontinence, and cognitive decline or dementia. The dementia risk is particularly striking. Among patients with enlarged ventricles and at least one of these symptoms, the incidence of dementia was high across all groups during follow-up, and by the end of the observation period, roughly 59 percent had developed dementia. Even among patients who initially responded well to shunt surgery, 46 percent eventually became demented.

Hydrocephalus ex vacuo, by contrast, typically presents with symptoms of whatever is causing the brain to shrink. In Alzheimer’s disease, that means progressive memory loss, confusion, and personality changes. The enlarged ventricles themselves are not directly causing those symptoms; they are a visible consequence of the same disease process.

How Doctors Measure and Diagnose It

Ventricular enlargement is usually spotted on CT or MRI scans. The most widely used measurement is the Evans Index, which compares the maximum width of the frontal horns of the lateral ventricles to the widest internal diameter of the skull. A value above 0.3 has long been the standard threshold for diagnosing hydrocephalus, and large population studies have confirmed that this cutoff holds regardless of sex, age, or ethnicity.

¹³

But the Evans Index alone cannot distinguish between hydrocephalus and hydrocephalus ex vacuo. In both conditions, the ventricles are large. Doctors look for additional clues: in true hydrocephalus, the temporal horns of the ventricles tend to be disproportionately dilated, while the grooves on the brain surface (sulci) may appear compressed. In brain atrophy, those surface grooves are typically widened because the brain is shrinking everywhere. Even so, the distinction is not always clean; in one early study, about 43 percent of patients with brain atrophy showed no visible widening of the cortical sulci, complicating the picture.

¹⁴

Newer approaches are improving diagnostic accuracy. Automated MRI brain tissue segmentation, which measures the actual volume of gray matter and ventricular space, has shown high accuracy in separating shunt-responsive NPH from Alzheimer’s-related brain atrophy. Patients with NPH tend to have high ventricular volumes but near-normal gray matter volumes, while Alzheimer’s patients show both enlarged ventricles and significant gray matter loss.

¹⁵

Another key tool is the callosal angle, which measures the angle formed by the lateral ventricles when viewed from the front on MRI. A tighter angle suggests active hydrocephalus pushing the ventricle walls apart. Researchers have also proposed the anterior lateral ventricular index as a potentially more sensitive linear measure. In one study of iNPH patients who underwent shunt surgery, both the Evans Index and this newer index decreased significantly after the procedure, while the callosal angle widened, reflecting the expected reduction in ventricular size.

¹⁶

Beyond imaging, functional tests help determine whether surgery is likely to help. A high-volume lumbar tap test, in which doctors drain a measured amount of CSF through a spinal needle, is a relatively simple way to predict whether a patient’s symptoms will improve with a permanent shunt. If walking, cognition, or continence get better after the tap, it is a good sign that the ventricles are contributing to symptoms and that surgical drainage could help.

¹⁷

Surgical Treatment Options

When ventricular enlargement is caused by active hydrocephalus, surgery is almost always the answer. Two main approaches dominate.

Shunts

Ventriculoperitoneal (VP) shunts remain the workhorse of hydrocephalus treatment. A thin tube is inserted into a ventricle and tunneled under the skin to the abdominal cavity, where excess CSF is absorbed. The system includes a valve that regulates flow. Early VP shunts from the 1970s had high complication rates and modest improvement in symptoms, but the development of programmable-pressure valves has changed the landscape. Modern valves can be adjusted non-invasively after implantation, reducing complications related to over- or under-drainage.

¹⁸

Shunts work well but are not problem-free. They can become blocked, infected, or disconnected, sometimes requiring revision surgery. Despite decades of refinement, shunt dependence remains a lifelong concern for many patients.

Endoscopic Third Ventriculostomy

Endoscopic third ventriculostomy (ETV) offers a shunt-free alternative for some patients. A tiny camera is threaded into the ventricles, and the surgeon creates a small hole in the floor of the third ventricle. This allows CSF to bypass any blockage and flow directly into the spaces around the brain where it can be absorbed. ETV is particularly effective in obstructive hydrocephalus caused by aqueductal stenosis, where success rates above 90 percent have been reported.

¹⁹

A systematic review and meta-analysis comparing ETV to VP shunts in adults with long-standing overt ventriculomegaly found broadly similar success rates, around 82 percent for ETV and 87 percent for VP shunts. But the complication rates told a different story: about 5 percent for ETV versus 27 percent for shunts.

²⁰

That significantly lower complication rate with ETV has fueled growing interest in using it as a first-line option, though evidence is still insufficient to universally recommend one approach over the other for all types of hydrocephalus.

²¹

In young children, particularly infants under two, ETV is sometimes combined with choroid plexus cauterization, a procedure that reduces CSF production at its source. Early results from a prospective series suggest this combined approach can decrease the likelihood that the child will need a shunt later.

²²

What About Medications?

There is no drug that reliably treats hydrocephalus. Diuretics like acetazolamide and furosemide have been used in premature infants with post-hemorrhagic ventricular dilation in hopes of avoiding shunt surgery. But a randomized controlled trial found that this combination was not only ineffective at reducing the need for shunts but was actually associated with increased neurological problems. The researchers concluded the treatment cannot be recommended.

²³

Medications do play a supporting role in managing symptoms. Drugs to control seizures, treat headaches, or address behavioral and cognitive symptoms may be part of the broader treatment plan. But they do not address the underlying fluid imbalance or replace surgical intervention when it is needed.

Long-Term Outlook

Outcomes after treatment depend heavily on the cause, the patient’s age, how long the condition went untreated, and whether complications arise.

In children treated surgically for hydrocephalus, the results span a wide range. One long-term follow-up found that about 30 percent of children achieved IQ scores above 90 (the normal range), while another quarter fell between 70 and 90, and the remaining children had more significant intellectual disability. Nearly 70 percent had some neurological deficit, and about one in five had visual or hearing problems. Still, almost 59 percent were able to attend mainstream schools, and shunt malfunction was clearly linked to worse developmental outcomes.

²⁴

For adults with iNPH, shunt surgery can be dramatically effective in the short term. In one series, 92 percent of patients improved after surgery. But the benefits tend to erode over time: after a decade, 76 percent still showed improvement, and systematic reviews report improvement rates around 81 to 82 percent at one year, declining to about 73 percent beyond three years.

²⁵

Brain tissue does show the capacity to recover after successful shunting. Imaging studies have demonstrated that compressed brain tissue can expand and partially regain its structure once CSF drainage is restored.

²⁶

The Role of Ependymal Cilia in Ventricular Stretching

One of the more intriguing lines of research into why ventricles enlarge focuses on tiny hair-like structures called motile cilia that line the inner walls of the ventricles. These cilia beat in coordinated waves to help move CSF through the ventricular system. In iNPH, a self-reinforcing cycle appears to develop: as CSF pulsations become stronger and more turbulent, the oscillatory shear stress on the ventricle walls increases. That stress damages and eventually strips away the cilia and the ependymal cells that anchor them. Without ciliary protection, the ventricle walls are directly exposed to even more mechanical force. There is also evidence that increased shear stress may activate signaling pathways in the ventricle walls that cause them to stretch and dilate, similar to how blood vessels widen in response to flow changes.

¹²

The majority of gene mutations known to cause communicating hydrocephalus are linked to abnormal structure or dysfunction of these same motile cilia, which reinforces the idea that ciliary health is central to keeping the ventricular system stable. This is still an active area of investigation, but it represents one of the more promising avenues for eventually developing non-surgical treatments that target the mechanisms of ventricular enlargement rather than just draining excess fluid.

Early Surgical Innovations

The history of treating ventricular enlargement is longer than most people realize. Hippocrates and Galen both described hydrocephalus cases in antiquity, though they mistakenly believed the fluid accumulated outside the brain rather than within it. The first detailed description of draining intracranial fluid in a hydrocephalic child came in the tenth century, from the Arab surgeon Abulkassim Al Zahrawi. But meaningful progress required both sterile surgical technique and an understanding of how CSF actually circulates, neither of which existed before the late 1800s. The first sterile ventricular puncture with external CSF drainage was performed in 1881, serial lumbar punctures began in 1891, and the first permanent internal shunt was implanted in 1893. Between 1898 and 1925, surgeons experimented with routing CSF to the peritoneal cavity, the bloodstream, the chest cavity, and even the ureter, but most of these early shunts failed due to poor materials.

²⁷

Modern shunt materials and programmable valves have made the procedure far safer and more reliable, but the basic concept of diverting excess CSF to another body cavity where it can be absorbed has remained essentially unchanged for over a century. The fact that we are still refining variations on an idea from the 1890s speaks to both how well the underlying principle works and how difficult it has been to find fundamentally different solutions.